Patent Protection and Trends in AI driven Drug Discovery.
Joseph Wyse, Joe Wyse Patent Office, Hadera, Israel (joewysepatents@gmail.com)
Patent Protection and Trends in AI driven Drug discovery Innovation.
The integration of artificial intelligence (AI) within drug discovery is reshaping the pharmaceutical landscape by accelerating and optimizing various stages of the drug development process. This presentation examines the evolving patent landscape associated with AI technologies in drug discovery, highlighting emerging trends, challenges, and strategic considerations for stakeholders in the field.
AI technologies, including machine learning and predictive analytics, are transforming key areas such as target identification, lead optimization, and drug repurposing. These innovations promise reduced development timelines, cost savings, and enhanced success rates in bringing new therapeutics to market. However, this rapid evolution poses complex patent challenges, including issues related to algorithm patentability, data privacy, and intellectual property rights management.
Through an analysis of recent patent filings and case studies, this presentation will discuss strategic approaches for securing robust patent protection in this dynamic field, focusing on the intersection of biotechnology, computational models, and pharmaceutical innovations. We will also explore the patent trends relevant to AI applications in drug discovery and medical preparations.
By examining these aspects, this presentation aims to provide insights into best practices for navigating the patent system and forming strategic partnerships, ultimately fostering innovation while ensuring legal and commercial viability. This session will be invaluable for researchers, and industry leaders interested in leveraging AI to drive future advances in drug discovery and development.
Short Biography of Presenting Author
Dr. Joseph I. Wyse
Bsc (hons)., Ph.D., IL Patent Attorney Licence #442
Tel: ++972(0)54 8777 300
e-mail: joewysepatents@gmail.com
CAREER HISTORY
Patent Practitioner & Patent Consultant at: The Wyse Patent Practice; Hadera; Israel
Areas of Speciality:
Patent Prosecution
Patent Portfolio Management
Patent Driven Business Intelligence
Patent Valuation
Technology Transfer
Patent Due Diligence
Patent Infringement Detection
Patent Litigation Monitoring
Partner, Director of Patent Dept. Dr. Eyal Bressler & Co. Ltd. 2006-October 2024
Built and directed a Patent Department of 25 patent attorneys, patent associates, lawyers and scientific consultants.
Responsible for IP protection in biotech, pharma, medtech, Healthcare, agritech, engineering, fintech and Adtech. Pioneer in patenting emerging technologies: blockchain, AI, and robotics. I have consistently extended the patent protection to achieve protection and value enhancement for my client's businesses.
1983-2006
PhD in Genetics from the University of London
Science Research Council Research Fellow University of London
Technion Institute of Technology Israel; Lady Davis Post Doc Fellow
Lead scientist at Haifa Genetics Ltd and Biolume Ltd.
CEO: Anglo Israel Control Systems
Societies and Conferences:
I've been a frequent participant and contributor to conferences of the Israel Chemical Society, World Food Organisation, Controlled Release Society, Forum on IP Protection of Plant Innovations, OECD, Food and Drug Law Institute, LES,Copenhagen Medical hub and more.